{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:09:24Z","timestamp":1765667364744,"version":"3.40.5"},"reference-count":23,"publisher":"American Academy of Pediatrics (AAP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,1]]},"abstract":"<jats:sec><jats:title>OBJECTIVES<\/jats:title><jats:p>Although ceftriaxone has been the first-line treatment of Lyme meningitis, the 2020 Infectious Disease Society of America, American College of Rheumatology, and American Academy of Neurology guideline recommends either doxycycline or ceftriaxone. Our objective was to explore recent trends in enteral antibiotic treatment of children with Lyme meningitis.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>Using International Classification of Diseases, 10th Revision codes for case identification, we performed a multicenter retrospective study of patients \u226421 years of age presenting to a pediatric hospital contributing to the Pediatric Health Information System who were diagnosed with Lyme meningitis from 2015 to 2020. Our primary outcome was treatment with parenteral antibiotics, defined by either a procedure code for indwelling catheter placement or &amp;gt;7 days of inpatient parenteral Lyme disease\u2013specific therapy. To examine trends over the study period, we used a generalized estimating equation, with parenteral antibiotics as the dependent variable and study year as the independent variable, adjusted for patient age, sex, race, ethnicity, and insurance status clustered by hospital.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>We identified 239 patients with Lyme meningitis treated at 24 participating centers. Overall, 48 (20.0%) were treated with parenteral antibiotics, with a declining rate over the study period (43.8% in 2015 to 8.9% in 2020). After adjustment, the odds of treatment with a parenteral antibiotic decreased over the study period (adjusted odds ratio 0.57; 95% confidence interval 0.41\u20130.80).<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>Parenteral antibiotic treatment of children with Lyme meningitis has been on the decline in advance of the published clinical guideline. Carefully designed comparative effectiveness studies are needed to examine the effect of oral versus parenteral treatment regimens on clinical outcomes.<\/jats:p><\/jats:sec>","DOI":"10.1542\/hpeds.2021-005909","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T09:28:30Z","timestamp":1633080510000},"page":"e243-e248","source":"Crossref","is-referenced-by-count":3,"title":["Changes in Antibiotic Treatment for Children With Lyme Meningitis 2015\u20132020"],"prefix":"10.1542","volume":"11","author":[{"given":"Kelly M.","family":"Roelf","sequence":"first","affiliation":[{"name":"Department of Medicine and"},{"name":"Department of Pediatrics, Harvard Medical School, Boston, Massachusetts; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aris","family":"Garro","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Emergency Medicine, Rhode Island Hospital, Providence, Rhode Island"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C.","family":"Monuteaux","sequence":"additional","affiliation":[{"name":"Division of Emergency Medicine, Boston Children\u2019s Hospital, Boston, Massachusetts;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise E.","family":"Nigrovic","sequence":"additional","affiliation":[{"name":"Division of Emergency Medicine, Boston Children\u2019s Hospital, Boston, Massachusetts;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"issue":"9","key":"2021121008175163900_b1","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"10","key":"2021121008175163900_b2","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/INF.0b013e31825eb3c7","article-title":"Treatment complications in children with lyme meningitis","volume":"31","author":"Thompson","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"2021121008175163900_b3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1517\/14740338.2016.1133584","article-title":"Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation?","volume":"15","author":"Cross","year":"2016","journal-title":"Expert Opin Drug Saf"},{"issue":"11","key":"2021121008175163900_b4","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1177\/1060028019863796","article-title":"Doxycycline and tooth discoloration in children: changing of recommendations based on evidence of safety","volume":"53","author":"Stultz","year":"2019","journal-title":"Ann Pharmacother"},{"issue":"8","key":"2021121008175163900_b5","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/BF00328508","article-title":"Treatment of Lyme borreliosis. Randomized comparison of doxycycline and penicillin G","volume":"236","author":"Kohlhepp","year":"1989","journal-title":"J Neurol"},{"issue":"7","key":"2021121008175163900_b6","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1212\/WNL.44.7.1203","article-title":"Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis","volume":"44","author":"Karlsson","year":"1994","journal-title":"Neurology"},{"issue":"6\u20137","key":"2021121008175163900_b7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/00365540510027228","article-title":"Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis","volume":"37","author":"Borg","year":"2005","journal-title":"Scand J Infect Dis"},{"issue":"8","key":"2021121008175163900_b8","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1474-4422(08)70119-4","article-title":"Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial","volume":"7","author":"Lj\u00f8stad","year":"2008","journal-title":"Lancet Neurol"},{"issue":"3","key":"2021121008175163900_b9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/jpids\/piy072","article-title":"Oral management for pediatric Lyme meningitis","volume":"8","author":"Lopez","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"1","key":"2021121008175163900_b10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciaa1215","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis and treatment of Lyme disease","volume":"72","author":"Lantos","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2021121008175163900_b11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/art.41562","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis, and treatment of Lyme disease","volume":"73","author":"Lantos","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"2021121008175163900_b12","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1212\/WNL.0000000000011151","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology: 2020 guidelines for the prevention, diagnosis, and treatment of Lyme disease","volume":"96","author":"Lantos","year":"2021","journal-title":"Neurology"},{"issue":"1 pt 2","key":"2021121008175163900_b13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1542\/peds.106.S1.205","article-title":"Pediatric deaths attributable to complex chronic conditions: a population-based study of Washington State, 1980-1997","volume":"106","author":"Feudtner","year":"2000","journal-title":"Pediatrics"},{"issue":"1","key":"2021121008175163900_b14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1542\/hpeds.2017-0045","article-title":"Variation in pediatric procedural sedations across children\u2019s hospital emergency departments","volume":"8","author":"Miller","year":"2018","journal-title":"Hosp Pediatr"},{"issue":"2","key":"2021121008175163900_b15","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1001\/jamapediatrics.2014.2822","article-title":"Comparative effectiveness of intravenous vs oral antibiotics for postdischarge treatment of acute osteomyelitis in children","volume":"169","author":"Keren","year":"2015","journal-title":"JAMA Pediatr"},{"issue":"1","key":"2021121008175163900_b16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/654809","article-title":"Final report of the Lyme disease review panel of the Infectious Diseases Society of America","volume":"51","author":"Lantos","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2021121008175163900_b17","doi-asserted-by":"crossref","DOI":"10.1542\/peds.99.2.e4","article-title":"Survey of the use of peripherally inserted central venous catheters in children","volume":"99","author":"Thiagarajan","year":"1997","journal-title":"Pediatrics"},{"issue":"12","key":"2021121008175163900_b18","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/INF.0b013e31817d32f2","article-title":"Experience using peripherally inserted central venous catheters for outpatient parenteral antibiotic therapy in children at a community hospital","volume":"27","author":"Van Winkle","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"2021121008175163900_b19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/INF.0b013e3181c94d9e","article-title":"Infectious complications of peripherally inserted central venous catheters in children","volume":"29","author":"Levy","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"2021121008175163900_b20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/INF.0b013e31824571b0","article-title":"Frequency of peripherally inserted central catheter complications in children","volume":"31","author":"Barrier","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"2021121008175163900_b21","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jaip.2019.11.035","article-title":"Adverse reactions associated with penicillins, carbapenems, monobactams, and clindamycin: a retrospective population-based study","volume":"8","author":"Liang","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"2021121008175163900_b22","doi-asserted-by":"crossref","first-page":"101418","DOI":"10.1016\/j.ttbdis.2020.101418","article-title":"Development of a pediatric Lyme meningitis symptom measurement instrument using a Delphi technique","volume":"11","author":"Garro","year":"2020","journal-title":"Ticks Tick Borne Dis"},{"issue":"3","key":"2021121008175163900_b23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1542\/peds.2014-1278","article-title":"Variation in emergency department admission rates in US children\u2019s hospitals","volume":"134","author":"Bourgeois","year":"2014","journal-title":"Pediatrics"}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/11\/10\/e243\/1191368\/hpeds_2021-005909.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/11\/10\/e243\/1191368\/hpeds_2021-005909.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T20:25:09Z","timestamp":1699561509000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/11\/10\/e243\/181169\/Changes-in-Antibiotic-Treatment-for-Children-With"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":23,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10,1]]},"published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/hpeds.2021-005909","relation":{},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"type":"print","value":"2154-1663"},{"type":"electronic","value":"2154-1671"}],"subject":[],"published":{"date-parts":[[2021,10,1]]}}}